KEMPHARM, INC (KMPH) has 71 open-market insider trades by 14 insiders since 2015. The most active filer is R. LaDuane Clifton, CFO & Secretary.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Delaware Street Capital Master Fund, L.P. | 10% Owner | — | 2 | $8.1M | 2018-10-05 |
| DSC Advisors, L.L.C. | 10% Owner | — | 1 | $1.2M | 2018-07-30 |
| Travis C. Mickle | Pres | — | 12 | $306K | 2022-05-25 |
| Daniel L. Cohen | VP | — | 7 | $168K | 2018-05-15 |
| Richard W. Pascoe | CEO | — | 4 | $144K | 2023-01-13 |
| David S. Tierney | Dir | — | 5 | $90K | 2022-05-25 |
| Samuel J. Braun | 10% Owner | — | 1 | $86K | 2021-05-13 |
| Christal M. M. Mickle | VPOperations & Product Dvlp.10% | — | 3 | $69K | 2017-03-22 |
| R. LaDuane Clifton | CFOSecretary | — | 25 | $64K | 2023-01-13 |
| Gordon K. Johnson | Chief Business Officer | — | 5 | $55K | 2019-12-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| R. LaDuane Clifton | CFO & Secretary | Buy | $4K | 2023-01-13 |
| Richard W. Pascoe | CEO | Buy | $103K | 2023-01-13 |
| R. LaDuane Clifton | CFO & Secretary | Buy | $6K | 2022-09-30 |
| David S. Tierney | Director | Buy | $9K | 2022-05-25 |
| Travis C. Mickle | President | Buy | $57K | 2022-05-25 |
| Tamara A. Seymour | Director | Buy | $974 |
Companies that share insiders with KMPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-05-20 |
| R. LaDuane Clifton | CFO & Secretary | Buy | $6K | 2022-05-18 |
| Matthew R. Plooster | Director | Buy | $25K | 2022-05-18 |
| Richard W. Pascoe | Chairman | Buy | $23K | 2022-05-18 |
| Richard W. Pascoe | Chairman | Buy | $12K | 2021-11-30 |
| David S. Tierney | Director | Buy | $16K | 2021-11-30 |
| Travis C. Mickle | President | Buy | $19K | 2021-11-18 |
| R. LaDuane Clifton | CFO & Secretary | Buy | $4K | 2021-11-18 |
| R. LaDuane Clifton | CFO & Secretary | Buy | $2K | 2021-09-29 |
| R. LaDuane Clifton | CFO & Secretary | Buy | $8K | 2021-09-20 |